DK3660045T3 - Polypeptid, fremgangsmåde til fremstilling deraf og anvendelse deraf - Google Patents
Polypeptid, fremgangsmåde til fremstilling deraf og anvendelse deraf Download PDFInfo
- Publication number
- DK3660045T3 DK3660045T3 DK19211389.2T DK19211389T DK3660045T3 DK 3660045 T3 DK3660045 T3 DK 3660045T3 DK 19211389 T DK19211389 T DK 19211389T DK 3660045 T3 DK3660045 T3 DK 3660045T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- preparation
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811438582.6A CN109593126B (zh) | 2018-11-28 | 2018-11-28 | 多肽、其生产方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3660045T3 true DK3660045T3 (da) | 2024-09-09 |
Family
ID=65959862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19211389.2T DK3660045T3 (da) | 2018-11-28 | 2019-11-26 | Polypeptid, fremgangsmåde til fremstilling deraf og anvendelse deraf |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11396537B2 (da) |
| EP (1) | EP3660045B1 (da) |
| CN (1) | CN109593126B (da) |
| DK (1) | DK3660045T3 (da) |
| ES (1) | ES2986457T3 (da) |
| FI (1) | FI3660045T3 (da) |
| HR (1) | HRP20241179T1 (da) |
| HU (1) | HUE068092T2 (da) |
| LT (1) | LT3660045T (da) |
| PL (1) | PL3660045T3 (da) |
| PT (1) | PT3660045T (da) |
| RS (1) | RS65903B1 (da) |
| SI (1) | SI3660045T1 (da) |
| SM (1) | SMT202400340T1 (da) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109593126B (zh) | 2018-11-28 | 2019-11-22 | 山西锦波生物医药股份有限公司 | 多肽、其生产方法和用途 |
| CN113440431A (zh) * | 2021-08-02 | 2021-09-28 | 山西锦波生物医药股份有限公司 | 重组ⅲ型人源化胶原蛋白在头皮护理中的用途及包含其的头皮护理产品 |
| CN113713086A (zh) * | 2021-08-20 | 2021-11-30 | 山西锦波生物医药股份有限公司 | 一种含有重组iii型人源化胶原蛋白的组合物及其制备方法和用途 |
| CN113621052B (zh) * | 2021-08-23 | 2022-06-07 | 山西锦波生物医药股份有限公司 | 一种重组i型人源化胶原蛋白多肽及其制备方法和用途 |
| CN113476593A (zh) * | 2021-08-25 | 2021-10-08 | 山西锦波生物医药股份有限公司 | 重组人源化胶原蛋白的用途及其相关组合物和制备方法 |
| CN113730557B (zh) * | 2021-09-03 | 2023-12-22 | 山西锦波生物医药股份有限公司 | 重组i型人源化胶原蛋白在盆底修复中的用途 |
| CN114085284B (zh) * | 2021-11-19 | 2022-11-08 | 西安德诺海思医疗科技有限公司 | 一种重组iii型人源化胶原蛋白、核酸、载体及植入剂 |
| CN114106111B (zh) * | 2021-11-28 | 2023-04-11 | 中国人民解放军军事科学院军事医学研究院 | 一种高黏附力多肽及其用途 |
| CN114276435B (zh) * | 2021-12-29 | 2023-12-01 | 广州赛莱拉干细胞科技股份有限公司 | 一种重组人源ⅲ型胶原蛋白及其应用 |
| CN114632022A (zh) * | 2022-03-17 | 2022-06-17 | 山西锦波生物医药股份有限公司 | 一种胶原蛋白冻干纤维及其制备方法和应用 |
| CN114917407B (zh) * | 2022-05-07 | 2023-10-20 | 四川大学 | 具有心肌组织修复功能的抗心衰可注射水凝胶及其制备方法和应用 |
| EP4509136A4 (en) * | 2022-05-13 | 2025-08-20 | Shanxi Jinbo Bio Pharmaceutical Co Ltd | FUSION PROTEIN AND ITS USE |
| CN114940712B (zh) * | 2022-06-01 | 2023-12-26 | 山西锦波生物医药股份有限公司 | 一种生物合成人体结构性材料的制备方法 |
| CN114920827B (zh) | 2022-06-29 | 2023-06-09 | 山西锦波生物医药股份有限公司 | 多肽及其用途 |
| CN117143223B (zh) * | 2022-08-23 | 2024-03-08 | 山西锦波生物医药股份有限公司 | 一种生物合成人体结构性材料的制备方法 |
| CN115947827B (zh) * | 2022-10-08 | 2025-02-18 | 四川大学 | 一种重组胶原蛋白及其在软骨修复基质中的用途 |
| CN118146352A (zh) * | 2022-12-06 | 2024-06-07 | 武汉佳惟达生物科技有限公司 | 胶原蛋白肽及其制备方法和用途 |
| CN115960211B (zh) * | 2022-12-23 | 2023-11-21 | 江苏创健医疗科技股份有限公司 | 一种重组人源ⅵ型胶原蛋白及其制备方法和应用 |
| CN117229386B (zh) * | 2023-03-16 | 2025-05-23 | 山西锦波生物医药股份有限公司 | 一种具有164.88°三螺旋结构低分子量胶原蛋白 |
| CN118047857B (zh) * | 2023-03-24 | 2024-11-15 | 山西锦波生物医药股份有限公司 | 一种生物合成人体结构性材料的制备方法 |
| CN116617371A (zh) * | 2023-05-29 | 2023-08-22 | 山西锦波生物医药股份有限公司 | 重组iii型人源化胶原蛋白在卵巢癌治疗中的用途 |
| CN116836264B (zh) * | 2023-06-01 | 2024-02-20 | 广东完美生命健康科技研究院有限公司 | 一种重组人源化纤连蛋白rhFEB及应用 |
| EP4717271A1 (en) * | 2023-07-19 | 2026-04-01 | Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. | 164.88-degree recombinant humanized type iii collagen for vascular repair |
| CN116813751B (zh) | 2023-08-04 | 2025-03-21 | 山西锦波生物医药股份有限公司 | 自交联重组人源化胶原蛋白高分子生物材料及其制备方法 |
| CN118290567A (zh) * | 2023-08-28 | 2024-07-05 | 科兴生物制药股份有限公司 | 重组人源化iii型三螺旋胶原蛋白及其制备方法和应用 |
| CN117126874B (zh) * | 2023-09-28 | 2024-04-16 | 山西锦波生物医药股份有限公司 | 大规模制备164.88°三螺旋结构胶原蛋白生物方法 |
| WO2025076821A1 (en) | 2023-10-13 | 2025-04-17 | L'oreal | Composition and method using the same |
| CN117069827B (zh) * | 2023-10-17 | 2023-12-22 | 北京世纪伟信医药科技有限公司 | 一种重组胶原重复序列蛋白的表达及其应用 |
| CN117447582A (zh) * | 2023-10-27 | 2024-01-26 | 陕西巨子生物技术有限公司 | 一种新的重组胶原蛋白、其制备方法及用途 |
| CN117510619B (zh) * | 2023-12-22 | 2024-03-12 | 南京天纵易康生物科技股份有限公司 | 一种创新空间结构的重组ⅲ型人源化胶原蛋白微球及其设计、制备工艺和应用 |
| CN117903288B (zh) * | 2024-01-25 | 2024-08-20 | 广州市科臣生物技术有限公司 | 一种重组iii型胶原蛋白水光精华液的制备方法及其功效测试方法 |
| CN118141987B (zh) * | 2024-03-01 | 2025-01-03 | 山西锦波生物医药股份有限公司 | 一种a型重组人源化胶原蛋白骨修复材料及其制备方法和用途 |
| CN118240064A (zh) * | 2024-03-21 | 2024-06-25 | 江西崇山生物制品有限公司 | 一种合成ⅲ型人源化胶原蛋白及其制备方法和应用 |
| CN118561987A (zh) * | 2024-08-01 | 2024-08-30 | 英特菲尔(成都)生物制品有限责任公司 | 一种可自组装的重组胶原蛋白及其制备方法与应用 |
| CN119390816B (zh) * | 2024-08-09 | 2026-03-27 | 山西锦波生物医药股份有限公司 | 一种新型重组人源化胶原蛋白水凝胶制备方法 |
| CN119242674A (zh) * | 2024-12-05 | 2025-01-03 | 山东义才和锐生物技术有限公司 | 一种重组表达质粒、构建重组人源化胶原蛋白大肠杆菌的方法和透皮型重组人源化胶原蛋白的制备方法及其用途 |
| CN120114574B (zh) * | 2024-12-16 | 2025-12-12 | 山西锦波生物医药股份有限公司 | 重组iii型人源化胶原蛋白在胃癌产品中的新用途 |
| CN119564836B (zh) * | 2024-12-31 | 2026-02-17 | 山西锦波生物医药股份有限公司 | 重组iii型人源化胶原蛋白在治疗宫颈癌中的用途 |
| CN120037359B (zh) * | 2025-01-16 | 2025-10-28 | 山西锦波生物医药股份有限公司 | 重组iii型人源化胶原蛋白及包含其的组合物在眼部的应用 |
| CN119909007B (zh) * | 2025-04-02 | 2025-06-03 | 四川大学 | 一种具有氧化还原活性和电活性的可注射水凝胶及其制备方法与应用 |
| CN119978111A (zh) * | 2025-04-15 | 2025-05-13 | 哈药集团生物工程有限公司 | 一种人源重组iii型胶原蛋白及其制备方法和应用 |
| CN120754232A (zh) * | 2025-07-09 | 2025-10-10 | 山西锦波生物医药股份有限公司 | 重组iii型人源化胶原蛋白在注射剂中的应用 |
| CN120988105B (zh) * | 2025-10-16 | 2026-02-06 | 北京祥原生物科技有限公司 | 一种人源胶原蛋白的制备方法及其在抗衰老中的应用 |
| CN121293373A (zh) * | 2025-10-24 | 2026-01-09 | 德州康泽生物医药有限公司 | 一种具有抗衰老作用的胶原蛋白肽及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6969523B1 (en) * | 2001-10-19 | 2005-11-29 | Integra Lifesciences Corporation | Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation |
| EP2479277B1 (en) * | 2004-07-22 | 2015-09-02 | Five Prime Therapeutics, Inc. | Use of MGD-CSF in a method of treatment of Alzheimer's disease. |
| EP2698173A1 (en) * | 2008-02-29 | 2014-02-19 | Coloplast A/S | Compositions and methods for augmentation and regeneration of living tissue in a subject |
| EP2697370A1 (en) * | 2011-04-15 | 2014-02-19 | Universität Zürich Prorektorat MNW | Collagen hydroxylases |
| CN103122027B (zh) * | 2012-11-26 | 2014-05-14 | 杨霞 | 一种重组人源胶原蛋白及其生产方法 |
| EP2976352B1 (en) * | 2013-03-21 | 2021-08-18 | Evonik Operations GmbH | Purification of triple helical proteins |
| CN108822209A (zh) * | 2018-07-06 | 2018-11-16 | 山西锦波生物医药股份有限公司 | 多肽、其生产方法和用途 |
| CN109593126B (zh) * | 2018-11-28 | 2019-11-22 | 山西锦波生物医药股份有限公司 | 多肽、其生产方法和用途 |
-
2018
- 2018-11-28 CN CN201811438582.6A patent/CN109593126B/zh active Active
-
2019
- 2019-11-26 LT LTEP19211389.2T patent/LT3660045T/lt unknown
- 2019-11-26 RS RS20240937A patent/RS65903B1/sr unknown
- 2019-11-26 DK DK19211389.2T patent/DK3660045T3/da active
- 2019-11-26 FI FIEP19211389.2T patent/FI3660045T3/fi active
- 2019-11-26 PT PT192113892T patent/PT3660045T/pt unknown
- 2019-11-26 SI SI201930815T patent/SI3660045T1/sl unknown
- 2019-11-26 SM SM20240340T patent/SMT202400340T1/it unknown
- 2019-11-26 EP EP19211389.2A patent/EP3660045B1/en active Active
- 2019-11-26 HR HRP20241179TT patent/HRP20241179T1/hr unknown
- 2019-11-26 PL PL19211389.2T patent/PL3660045T3/pl unknown
- 2019-11-26 HU HUE19211389A patent/HUE068092T2/hu unknown
- 2019-11-26 ES ES19211389T patent/ES2986457T3/es active Active
- 2019-11-27 US US16/698,206 patent/US11396537B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE068092T2 (hu) | 2024-12-28 |
| RS65903B1 (sr) | 2024-09-30 |
| CN109593126A (zh) | 2019-04-09 |
| LT3660045T (lt) | 2024-09-10 |
| CN109593126B (zh) | 2019-11-22 |
| US20200165319A1 (en) | 2020-05-28 |
| ES2986457T3 (es) | 2024-11-11 |
| EP3660045A1 (en) | 2020-06-03 |
| US11396537B2 (en) | 2022-07-26 |
| PT3660045T (pt) | 2024-09-04 |
| SI3660045T1 (sl) | 2024-10-30 |
| EP3660045B1 (en) | 2024-08-07 |
| HRP20241179T1 (hr) | 2024-11-22 |
| SMT202400340T1 (it) | 2024-11-15 |
| PL3660045T3 (pl) | 2024-12-02 |
| FI3660045T3 (fi) | 2024-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3660045T3 (da) | Polypeptid, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK4186920T3 (da) | Ultra-langtidsvirkende insulin-fc-fusionsproteiner og fremgangsmåder til anvendelse | |
| DK4053160T3 (da) | Humant kollagen 17-type-polypeptid, fremgangsmåde til fremstilling og anvendelse heraf | |
| DK3774789T3 (da) | BRM-målrettede forbindelser og tilhørende fremgangsmåder til anvendelse | |
| DK3784283T3 (da) | Cannabidiopræparater og anvendelser deraf | |
| DK3794024T3 (da) | Aktiverbare interleukin-2 polypeptider og fremgangsmåder til anvendelse heraf | |
| DK3761980T3 (da) | Aminosyreforbindelser og fremgangsmåder til anvendelse | |
| DK3601358T3 (da) | Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3618863T3 (da) | Anti-tigit-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3618928T3 (da) | Anti-Sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3661954T3 (da) | Interleukin-21-muteiner og fremgangsmåder til behandling | |
| DK3788044T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3453707T3 (da) | Benzazepinderivat, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3565579T3 (da) | Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| DK3694529T3 (da) | Trispecifikke proteiner og anvendelsesfremgangsmåder | |
| DK3728121T3 (da) | Lanthaniddoterede, lagdelte dobbelthydroxider og fremgangsmåde til fremstilling af samme | |
| DK3259597T3 (da) | Pvrig-polypeptider og fremgangsmåder til behandling | |
| DK3298043T3 (da) | SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse | |
| DK3368571T5 (da) | Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf | |
| DK3565828T3 (da) | Sirp1 alpha-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf | |
| IL280809B (en) | Novel compositions, their use, and methods for their formation | |
| DK3525583T3 (da) | Anti-c1s-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3744316T3 (da) | Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK3445925T3 (da) | Justerbar, kompakt løftekobling og fremgangsmåde til anvendelse | |
| DK4073098T3 (da) | Ultralangtidsvirkende insulin-Fc-fusionsproteiner og fremgangsmåder til anvendelse |